Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Speed Stick 24/7 Print, TV Campaign To Break In March

This article was originally published in The Tan Sheet

Executive Summary

Colgate-Palmolive will support the introduction of Speed Stick 24/7, a new line of men's antiperspirant/ deodorant products, with a $20 mil. marketing campaign, the company announced

You may also be interested in...



Lady Speed Stick Launch Targets A Natural Woman

Colgate-Palmolive is tapping into the natural products segment with the introduction of Lady Speed Stick Naturals antiperspirant

Lady Speed Stick Launch Targets A Natural Woman

Colgate-Palmolive is tapping into the natural products segment with the introduction of Lady Speed Stick Naturals antiperspirant

Colgate Herbal Whitening Leads New Product Lineup For Next Year

Colgate Herbal Whitening toothpaste will headline several new oral and personal care products slated to debut in the U.S. by early 2003

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel